Skip to content

Clinical trials

Phase 1 Adrenal Hyperplasia, Congenital trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenal Hyperplasia, Congenital Phase: Phase 1 Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20151
20171
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurocrine UK Limited2
Neurocrine Biosciences1
OMass Therapeutics Australia Proprietary Ltd1
University of Minnesota1
University of Texas Southwestern Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenal Hyperplasia, Congenital6
Adrenal Gland Diseases2
Adrenal Insufficiency2
Adrenocortical Hyperfunction2
Disorders of Sex Development2
Genetic Diseases, Inborn2
Hyperplasia2
Steroid Metabolism, Inborn Errors2
Urogenital Abnormalities2
Adrenogenital Syndrome1

Trials

Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.